New sound therapy can reduce blood pressure in hypertensive patients

A new noninvasive neurotechnology has been shown to lower blood pressure, improve heart rate variability and reduced migraine symptoms.

The procedure, which uses sound to balance brain frequencies between the left and right sides, was presented last week at the American Heart Association’s Council on Hypertension sessions, the organization said in a statement.

Called high-resolution, relational, resonance-based, electroenephalic mirroring (HIRREM), the neurotechnology uses scalp sensors to measure electrical activity in the brain and detect any imbalances. HIRREM translates dominant frequencies into computer-generated audible tones.

This study is part of a larger research initiative that is examining the effects of HIRREM on multiple conditions.

In the study, the researchers examined the impact of HIRREM on 10 men and women who all had stage one hypertension. Results showed that hypertensive patients show an average reduction in systolic blood pressure from 152 to 136 millimeters of mercury. They also saw a reduction in diastolic pressure from 97 to 81 mmHg.

“Most people have relatively balanced electrical activity between the right side and left sides of the brain,” Hossam A. Shaltout, PhD, lead author on the study and an assistant professor in the Hypertension and Vascular Research Center at Wake Forest School of Medicine in Winston-Salem, North Carolina, said in a statement. “Imbalance, with one side dominant or more active, may reflect autonomic dysregulation associated with the effects of chronic stress, which is thought to play a role in high blood pressure, migraines, insomnia, depression, hot flashes and more.”

Additionally, there were improvements in patients’ levels of insomnia and anxiety, and heart rate variability increased from 42 to 57 milliseconds on average.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."